The new consortium partners expand CSDR's ability to help accelerate life-saving discoveries and efficiently translate big data into smart data that generates valuable research results.
With the addition of non-profit partners, CSDR is uniquely positioned to not only serve the research community through access to patient-level clinical data from the pharmaceutical industry, but also as a resource through which academic-led clinical trial data now can be shared.
ClinicalStudyDataRequest.com is an online resource giving researchers access to patient-level clinical trial data from 14 pharmaceutical companies across multiple therapeutic areas.
Its multi-sponsor request system provides a secure process for researchers to request access to global clinical trial data through a publicly available website.
An independent review panel reviews data requests received from external researchers. Wellcome Trust provides secretarial support to this panel and oversees the review process.
ChemDiv extends CMC services collaboration supporting clinical development of ratutrelvir
NeuroKaire and Compass Pathways partner to advance AI-driven research in psychedelic psychiatry
BioArctic reports third-quarter royalties from Leqembi sales
GenSight Biologics secures FDA authorisation for expanded access to GS010/LUMEVOQ in the US
AnHorn Medicines reports positive results from US Phase I trial of AH-001
ArkBio commences Phase II clinical trial of AK0610
Curasight advances Phase 2 prostate cancer trial with Curium partnership
Thermo Fisher Scientific to acquire Clario Holdings, expanding clinical data capabilities
Hemogenyx Pharmaceuticals advances HG-CT-1 trial and opens paediatric recruitment